MGP Ingredients Earnings Calls
| Release date | Apr 29, 2026 |
| EPS estimate | $0.0400 |
| EPS actual | $0.150 |
| EPS Surprise | 275.00% |
| Revenue estimate | 105.321M |
| Revenue actual | 106.427M |
| Revenue Surprise | 1.05% |
| Release date | Feb 25, 2026 |
| EPS estimate | $0.490 |
| EPS actual | $0.630 |
| EPS Surprise | 28.57% |
| Revenue estimate | 132.851M |
| Revenue actual | 138.316M |
| Revenue Surprise | 4.11% |
| Release date | Oct 29, 2025 |
| EPS estimate | $0.620 |
| EPS actual | $0.85 |
| EPS Surprise | 37.10% |
| Revenue estimate | 132.842M |
| Revenue actual | 130.912M |
| Revenue Surprise | -1.45% |
| Release date | Jul 31, 2025 |
| EPS estimate | $0.640 |
| EPS actual | $0.97 |
| EPS Surprise | 51.56% |
| Revenue estimate | 131.622M |
| Revenue actual | 145.494M |
| Revenue Surprise | 10.54% |
Last 4 Quarters for MGP Ingredients
Below you can see how MGPI performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $28.28 |
| EPS estimate | $0.640 |
| EPS actual | $0.97 |
| EPS surprise | 51.56% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $31.84 |
| Jul 28, 2025 | $30.97 |
| Jul 29, 2025 | $30.73 |
| Jul 30, 2025 | $29.37 |
| Jul 31, 2025 | $28.28 |
| Aug 01, 2025 | $27.93 |
| Aug 04, 2025 | $28.54 |
| Aug 05, 2025 | $28.43 |
| Aug 06, 2025 | $27.69 |
| 4 days before | -11.18% |
| 4 days after | -2.09% |
| On release day | -1.24% |
| Change in period | -13.03% |
| Release date | Oct 29, 2025 |
| Price on release | $24.69 |
| EPS estimate | $0.620 |
| EPS actual | $0.85 |
| EPS surprise | 37.10% |
| Date | Price |
|---|---|
| Oct 23, 2025 | $24.42 |
| Oct 24, 2025 | $24.33 |
| Oct 27, 2025 | $23.56 |
| Oct 28, 2025 | $23.67 |
| Oct 29, 2025 | $24.69 |
| Oct 30, 2025 | $24.19 |
| Oct 31, 2025 | $24.20 |
| Nov 03, 2025 | $24.14 |
| Nov 04, 2025 | $24.85 |
| 4 days before | 1.11% |
| 4 days after | 0.648% |
| On release day | -2.03% |
| Change in period | 1.76% |
| Release date | Feb 25, 2026 |
| Price on release | $20.34 |
| EPS estimate | $0.490 |
| EPS actual | $0.630 |
| EPS surprise | 28.57% |
| Date | Price |
|---|---|
| Feb 19, 2026 | $25.55 |
| Feb 20, 2026 | $25.93 |
| Feb 23, 2026 | $25.34 |
| Feb 24, 2026 | $25.81 |
| Feb 25, 2026 | $20.34 |
| Feb 26, 2026 | $19.78 |
| Feb 27, 2026 | $19.00 |
| Mar 02, 2026 | $19.17 |
| Mar 03, 2026 | $18.51 |
| 4 days before | -20.39% |
| 4 days after | -9.00% |
| On release day | -2.75% |
| Change in period | -27.55% |
| Release date | Apr 29, 2026 |
| Price on release | $19.16 |
| EPS estimate | $0.0400 |
| EPS actual | $0.150 |
| EPS surprise | 275.00% |
| Date | Price |
|---|---|
| Apr 23, 2026 | $20.19 |
| Apr 24, 2026 | $20.22 |
| Apr 27, 2026 | $20.25 |
| Apr 28, 2026 | $20.21 |
| Apr 29, 2026 | $19.16 |
| Apr 30, 2026 | $19.94 |
| May 01, 2026 | $19.40 |
| May 04, 2026 | $19.03 |
| May 05, 2026 | $19.97 |
| 4 days before | -5.10% |
| 4 days after | 4.23% |
| On release day | 4.07% |
| Change in period | -1.09% |
MGP Ingredients Earnings Call Transcript Summary of Q1 2026
MGP Ingredients reported Q1 2026 sales of $106.4M, adjusted EBITDA of $15M and adjusted EPS of $0.15 — all down year-over-year but ahead of Street expectations and in line with guidance. Management is executing a strategic refocus across its three segments: Branded Spirits (prioritizing ~10 core growth brands, continued investment in digital marketing, portfolio rationalization of ~45 tail SKUs to improve margins and free up capacity, with Penelope Bourbon and Yellowstone showing strength), Distilling Solutions (temporary idling of Kentucky distilling operations to align production with inventory, addition of brown-goods customers, slower-than-anticipated ramp of premium white-goods projects, and expected 2026 trough for the segment), and Ingredient Solutions (sales +29% driven by specialty proteins/starches, improved operational reliability but margin pressure from elevated effluent/waste disposal costs with mitigation actions planned during a Q2–Q3 shutdown). CFO reaffirmed 2026 guidance: net sales $480–500M, adjusted EBITDA $90–98M, adjusted EPS $1.50–1.80, full-year operating cash flow now expected $50–55M (free cash flow $30–35M) and net debt leverage to peak ~3.5x. A discrete noncash goodwill/asset impairment drove a GAAP net loss of $134.8M in Q1. Management emphasizes cost discipline, capex optimization (~$20M guidance), and actions to improve margins and cash generation over the balance of the year.
Sign In
Buy MGPI